<DOC>
	<DOCNO>NCT01111630</DOCNO>
	<brief_summary>The purpose study compare hemoglobin hematocrit variability three time weekly erythropoietin therapy anemia patient maintenance dialysis .</brief_summary>
	<brief_title>Study Erythropoietin ( EPO ) Administration Schedule</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Patients age 18 80 . Dialysis least 3 month . Epoetin treatment last 3 month . Baseline hemoglobin ( Hb ) value &gt; = 9.0 g/dL &lt; 13.0 g/dL . Baseline mean weekly epoetin maintenance dose â‰¤ 12,000 IU Patients agree participate study write . Hemoglobinopathies , i.e . sickle cell disease , thalassemia type . Hemolysis define Gastrointestinal bleed necessitate treatment ( medication , transfusion ) within last 3 month . Patients uncontrolled hypertension . Acute infection unstable systemic inflammatory disease . Current malignant disease . High likelihood early withdrawal interruption study ( e.g . severe disease within last 3 month , myocardial infarction , unstable angina , stroke , deep venous thrombosis ) . Life expectancy 12 month . Planned elective surgery study period . Blood transfusion within last 3 month . Pregnancy lactation . Other condition regard unsuitability investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>chronic renal failure</keyword>
	<keyword>Anaemia</keyword>
</DOC>